Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.14% | 3.77% | |||
| Total Other Revenue | 57.28% | -31.05% | |||
| Total Revenue | 3.46% | 3.46% | |||
| Cost of Revenue | 0.35% | 2.37% | |||
| Gross Profit | 4.92% | 3.98% | |||
| SG&A Expenses | 10.86% | 1.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.58% | 3.07% | |||
| Operating Income | -46.86% | 10.28% | |||
| Income Before Tax | -14.09% | -2.95% | |||
| Income Tax Expenses | 152.88% | 125.44% | |||
| Earnings from Continuing Operations | -91.21% | -23.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 90.59% | 24.83% | |||
| Net Income | -91.45% | -22.51% | |||
| EBIT | -46.86% | 10.28% | |||
| EBITDA | -26.65% | 3.77% | |||
| EPS Basic | -91.45% | -24.00% | |||
| Normalized Basic EPS | 17.91% | 8.94% | |||
| EPS Diluted | -91.45% | -23.23% | |||
| Normalized Diluted EPS | 18.56% | 11.49% | |||
| Average Basic Shares Outstanding | 1.46% | 1.56% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||